Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 292
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00869323 | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT00726739 | Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma | ||
| NCT02670837 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | ||
| NCT00623077 | MT2004-30: Tomotherapy for Solid Tumors | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT02722668 | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep | ||
| NCT00617188 | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer | ||
| NCT00609739 | Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | ||
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT03081780 | Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML | ||
| NCT01505569 | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | ||
| NCT00784524 | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT03850691 | Radiation and Combination Immunotherapy for Melanoma | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies | ||
| NCT03294304 | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy | ||
| NCT00276159 | Study of Immune Response Modifier in the Treatment of Hematologic Malignancies | ||
| NCT00903630 | Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | ||
| NCT00287911 | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT02948062 | Early Diagnosis Of Childhood Cerebral ALD | ||
| NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT01009437 | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer | ||
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT04740008 | Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices | ||
| NCT05700630 | Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT04105270 | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial | ||
| NCT00354172 | Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. | ||
| NCT00290641 | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT00455312 | Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA | ||
| NCT01593670 | Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes | ||
| NCT00432094 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT01581970 | Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer | ||
| NCT00376519 | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT00303719 | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | ||
| NCT02161783 | Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation | ||
| NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT03152526 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR | ||
| NCT02370160 | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma | ||
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | ||
| NCT02042924 | Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies |
